Form 8-K - Current report:
SEC Accession No. 0001564590-20-050793
Filing Date
2020-11-05
Accepted
2020-11-05 06:09:30
Documents
14
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrn-8k_20201105.htm   iXBRL 8-K 39148
2 EX-99.1 amrn-ex991_6.htm EX-99.1 644747
3 GRAPHIC gb4wamods45f000001.jpg GRAPHIC 5429
  Complete submission text file 0001564590-20-050793.txt   861405

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amrn-20201105.xsd EX-101.SCH 5784
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20201105_lab.xml EX-101.LAB 20164
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20201105_pre.xml EX-101.PRE 12069
7 EXTRACTED XBRL INSTANCE DOCUMENT amrn-8k_20201105_htm.xml XML 3777
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 201288487
SIC: 2834 Pharmaceutical Preparations